Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023
   Core EBITDA Growth(%) 347.3496.47-

What is the latest Core EBITDA Growth ratio of GENPHARMASEC ?

The latest Core EBITDA Growth ratio of GENPHARMASEC is 347.34 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025347.34
Mar202496.47
Mar2023-

How is Core EBITDA Growth of GENPHARMASEC Trending?

Years Core EBITDA Growth % Change
Mar2025 347.34
260.05
Mar2024 96.47
0
Mar2023 0 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹63.1 Cr -14.9% -1.7% -45.4% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,750.4 Cr -3.3% -3.8% -1.1% Stock Analytics
KIRI INDUSTRIES ₹2,609.2 Cr -4.9% -5.2% -20.2% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,523.3 Cr 1.7% -1.6% -32.3% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹996.5 Cr 0.3% -11.9% -9% Stock Analytics
BODAL CHEMICALS ₹585.3 Cr -1.7% -1.8% -18.5% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-14.9%

-1.7%

-45.4%

SENSEX

-3.7%

-2.5%

6.5%


You may also like the below Video Courses